Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Capecitabine
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Capecitabine
Tree Number(s)
D03.383.742.680.245.500.425
D03.383.742.698.875.404.425
D13.570.230.329.313
D13.570.685.245.500.425
Unique ID
D000069287
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069287
Scope Note
A deoxycytidine derivative and fluorouracil
PRODRUG
that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of
COLON CANCER
;
BREAST CANCER
and
GASTRIC CANCER
.
Entry Term(s)
N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Xeloda
Pharm Action
Antimetabolites, Antineoplastic
Related Numbers
154361-50-9
Public MeSH Note
2016; CAPECITABINE was indexed under DEOXYCYTIDINE and FLUOROURACIL 1998-2015
History Note
2016 (1998)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/27
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Pyrimidine Nucleosides [D03.383.742.680]
Cytidine [D03.383.742.680.245]
Deoxycytidine [D03.383.742.680.245.500]
Bromodeoxycytidine [D03.383.742.680.245.500.250]
Capecitabine [D03.383.742.680.245.500.425]
Emtricitabine [D03.383.742.680.245.500.600]
Gemcitabine [D03.383.742.680.245.500.775]
Zalcitabine [D03.383.742.680.245.500.950]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Pyrimidinones [D03.383.742.698]
Uracil [D03.383.742.698.875]
Fluorouracil [D03.383.742.698.875.404]
Capecitabine [D03.383.742.698.875.404.425]
Tegafur [D03.383.742.698.875.404.850]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleosides [D13.570]
Deoxyribonucleosides [D13.570.230]
Deoxycytidine [D13.570.230.329]
Bromodeoxycytidine [D13.570.230.329.100]
Capecitabine [D13.570.230.329.313]
Emtricitabine [D13.570.230.329.525]
Zalcitabine [D13.570.230.329.950]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleosides [D13.570]
Pyrimidine Nucleosides [D13.570.685]
Cytidine [D13.570.685.245]
Deoxycytidine [D13.570.685.245.500]
Bromodeoxycytidine [D13.570.685.245.500.250]
Capecitabine [D13.570.685.245.500.425]
Emtricitabine [D13.570.685.245.500.600]
Zalcitabine [D13.570.685.245.500.950]
Expand All
Collapse All
Capecitabine
Preferred
Concept UI
M0287377
Related Numbers
154361-50-9
Scope Note
A deoxycytidine derivative and fluorouracil
PRODRUG
that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of
COLON CANCER
;
BREAST CANCER
and
GASTRIC CANCER
.
Terms
Capecitabine
Preferred Term
Term UI
T000879330
Date
05/06/2015
LexicalTag
NON
ThesaurusID
N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Term UI
T317381
Date
01/01/1955
LexicalTag
NON
ThesaurusID
NLM (1998)
Xeloda
Narrower
Concept UI
M0374572
Terms
Xeloda
Preferred Term
Term UI
T400883
Date
11/26/1999
LexicalTag
TRD
ThesaurusID
NLM (1999)
page delivered in 0.144s